Advisory Panel Backs Approval Of Auxilium's Xiaflex, Wants Post-Market Data
This article was originally published in The Pink Sheet Daily
Executive Summary
Members agree 12-0 that drug is approvable, offer opinion on who should dispense and the amount of training needed.